Exposure to “high risk” partner(s) infected through: |
Male homosexual intercourse | 109 | 24 | 21 | 12 | 11 | 10 | 11 | 12 | 13 | 23 | 17 |
Injecting drug use | 199 | 37 | 31 | 41 | 33 | 49 | 48 | 23 | 22 | 36 | 16 |
Blood/blood products | 75 | 5 | 2 | 4 | 9 | 6 | 4 | 5 | 2 | 4 | 3 |
Exposure to presumed heterosexually infected partner(s): |
Exposure abroad |
in Africa | 1938 | 506 | 534 | 559 | 549 | 642 | 745 | 994 | 1478 | 2151 | 2338 |
in Latin America/Caribbean | 62 | 24 | 27 | 14 | 25 | 28 | 32 | 62 | 67 | 82 | 108 |
in Asia | 66 | 28 | 18 | 39 | 44 | 53 | 78 | 76 | 110 | 97 | 95 |
in North America | 56 | 16 | 9 | 8 | 8 | 10 | 15 | 7 | 6 | 9 | 4 |
in Europe | 127 | 38 | 36 | 42 | 42 | 50 | 42 | 49 | 46 | 46 | 41 |
in Australasia | 6 | 2 | 0 | 2 | 1 | 2 | 4 | 6 | 2 | 5 | 2 |
in country(ies) not known | 24 | 0 | 0 | 2 | 7 | 3 | 17 | 0 | 2 | 1 | 1 |
Exposure in the UK to partner(s) presumed infected |
outside Europe | 91 | 17 | 38 | 48 | 42 | 71 | 81 | 90 | 127 | 155 | 153 |
within Europe | 108 | 42 | 44 | 38 | 29 | 39 | 41 | 48 | 47 | 51 | 35 |
in country(ies) not known | 152 | 28 | 30 | 32 | 28 | 31 | 25 | 30 | 27 | 56 | 87 |
Partner(s) exposure category undetermined: |
Investigation continuing/closed | 24 | 2 | 6 | 10 | 7 | 11 | 17 | 25 | 32 | 113 | 252 |
Total | 3037 | 769 | 796 | 851 | 835 | 1005 | 1160 | 1427 | 1981 | 2829 | 3152 |